PHARMANEXT
ActiveSummary
The computed 12-month bankruptcy probability of PHARMANEXT is 2.1% (moderate). The 2025 annual accounts show equity of €531,183 and a net result of €169,596. Equity is growing by about 33% per year across the filed financial years. Its solvency ranks better than 34% of 12,482 sector peers (NACE 47, financial year 2025). The company has been active since 2018 and the Belgian Official Gazette contains no insolvency or warning signals.
Register details
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 9 October 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.
Recognitions · licences · registrations
Food safety, FASFC
1 siteSites & property
2 establishment units
2 parcels
| Cadastral parcel | Region | Area | Buildings | Height / floors |
|---|---|---|---|---|
| 54433E0564/00B004 | Wallonia | 1,465 m² | 1 · 213 m² | 8.1 m · 2 |
| 21446D0194/00T007 | Brussels | 510 m² | 1 · 342 m² | 30.6 m · 8 |